News and developments

Press Releases

Homburger advised on the sale of Biopas to Swixx Biopharma

On May 22, 2024, Swixx Biopharma, a Swiss-based global commercial platform dedicated to unlocking access to innovative medicines worldwide, announced its strategic expansion into Latin America by acquiring Laboratorios Biopas.
23 May 2024
Press Releases

Homburger advised Sonova AG on CHF 400 m credit facility

Homburger acted as counsel to Sonova AG in its capacity as borrower in connection with a Swiss law-governed CHF 400 m term and revolving credit facility agreement with UBS Switzerland AG as mandated lead arranger and agent for an international bank syndicate.
22 May 2024
Press Releases

Homburger advised DWS on Crypto ETPs

On March 27, 2024, Swiss special purpose issuance vehicle Xtrackers Digital Markets ETC AG simultaneously launched two series of crypto-linked Exchange Traded Products (ETPs) under its program for the issuance of cryptocurrency-focused ETPs for professional and retail investors in Europe.
10 April 2024
Press Releases

Homburger advised Meyer Burger on its CHF 206.75 m rights offering

On April 3, 2024, Meyer Burger Technology AG (SIX: MBTN) announced the successful completion of its rights offering, raising gross proceeds of CHF 206.75 m. Shares not subscribed by shareholders were placed with institutional investors at the prevailing market price.
10 April 2024
Press Releases

Homburger advised Coöperatieve Rabobank U.A. on a multicurrency credit facilities agreement

On December 18, 2023, Global TIP Holdings Two B.V. as company and Global TIP Finance B.V. as borrower received an increased EUR term facility under its existing multicurrency credit facilities agreement with ABN AMRO Bank N.V. as agent and Coöperatieve Rabobank U.A. as security agent, which is guaranteed by, inter alia, PEMA Truck- und Trailervermietung GmbH.
22 March 2024
Press Releases

Homburger advised the lenders represented by RBC Europe Limited in connection with the migration of Ionisos to the debt platform of 3i Investments plc

Homburger acted as counsel to the lenders represented by RBC Europe Limited in connection with the accession of EBD Irradiation Services AG, a company of the Ionisos group, to certain English law governed financing agreements relating to the debt platform of 3i Investments plc and the entry into certain Swiss law governed security agreements.
21 March 2024
Press Releases

Homburger advised UBS AG on its exchange offer of certain of its outstanding notes previously issued under its EMTN programme for SEC-registered notes, with notes in an amount of USD 1,970,083,000 being exchanged

On September 13, 2023, UBS AG, acting through its London branch, launched offers to exchange (i) any and all of its outstanding USD 1 bn 1.250 per cent. Notes due June 2026 for a like principal amount of new 1.250% Notes due June 1, 2026 and (ii) any and all of its outstanding USD 1 bn 4.500 per cent.
21 March 2024
Press Releases

Homburger advised the Alchemy Group on third amendment of term loan facility

On August 18, 2023, Alchemy US Holdco 1, LLC received an incremental USD term facility as a borrower under its existing credit arrangement with Wilmington Trust, National Association as administrative agent and collateral agent, which is guaranteed by, inter alia, Alchemy Transatlantic-S GmbH.
21 March 2024
Press Releases

Homburger advised AustralianSuper Pty Ltd. on its EUR 1.5 bn investment in Vantage Data Centers Europe

On September 12, 2023, AustralianSuper Pty Ltd. (AustralianSuper) announced the signing of a EUR 1.5 bn deal with DigitalBridge Group to acquire a significant minority stake in Vantage Data Centers Europe, Middle East and Africa (Vantage EMEA). AustralianSuper will join DigitalBridge as key shareholder in Vantage EMEA, one of the fastest growing hyperscale data center platforms in the region. The deal will support Vantage EMEA’s ambitious growth plans and enable the expansion and development of hyperscale data centers across EMEA to meet the growing demand from global big data and cloud computing companies. Homburger AG acted as Swiss legal counsel to AustralianSuper on this transaction. The Homburger team was led by Dieter Gericke (Corporate / M&A) and included Claudine Schär and Giulia Meier (both Corporate / M&A), Stefan Gäumann and Dominique Burà (both Real Estate) and Stefan Bindschedler (Financing and Investment Products). Herbert Smith Freehills acted as lead counsel to AustralianSuper.  
21 March 2024
Press Releases

Homburger advised Equinix, Inc. in connection with the issuance of CHF 300 m 2.875% bonds due in 2028

On September 12, 2023, Equinix, Inc., a globally leading digital infrastructure company, successfully completed its inaugural Swiss issuance of CHF 300 m 2.875% bonds due in 2028. The Bonds were issued by Equinix Europe 1 Financing Corporation LLC and are fully guaranteed by Equinix, Inc. The offering of the Bonds was done by reliance on Regulation S under the U.S. Securities Act.
21 March 2024
Press Releases

Homburger advised Nestlé on the issuance of an aggregate of USD 1.5 bn notes through an institutional (Rule 144A) offering in the United States of America

On September 12, 2023, Nestlé Holdings, Inc. successfully completed its issuance of USD 500 m 5.000% Notes due 2028, USD 500 m 5.000% Notes due 2030, and USD 500 m 5.000% Notes due 2033. The Notes are guaranteed by the Nestlé group's Swiss parent company Nestlé S.A. The offering of the Notes was done in reliance on Rule 144A and Regulation S under the U.S. Securities Act. Homburger advised Nestlé on all Swiss law aspects of the transaction. The Homburger team was led by Lee Saladino (Capital Markets), and included Daniel Daeniker (Corporate / M&A), Sofiya Shavlak (Capital Markets), and Dieter Grünblatt (Tax). Contact Nanding Susso / Marketing / [email protected]
21 March 2024
Press Releases

Homburger advises VectivBio with respect to the announced public cash tender offer from Ironwood Pharmaceuticals

On May 22, 2023, VectivBio Holding AG (Nasdaq: VECT), Basel (Switzerland), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare gas-trointestinal conditions, and Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, announced that they had entered into an agreement for Ironwood to launch an all-cash public tender offer to acquire all outstanding shares in VectivBio for USD 17 per share, with an estimated aggregate consideration of approximately USD 1 bn, net of VectivBio cash and debt.
21 March 2024
Press Releases

Homburger advised Meyer Burger Technology AG on the issuance of green senior unsecured guaranteed convertible bonds due 2029 in the amount of EUR 216.3 m

On May 17, 2023, Meyer Burger Technology AG (SIX: MBTN) (Meyer Burger) successfully issued green senior unsecured guaranteed convertible bonds due 2029 in the aggregate amount of EUR 216.3 m. The bonds were placed in a private placement with a coupon of 3.75% per annum. The bonds are issued by Meyer Burger's subsidiary MBT Systems GmbH and guaranteed by Meyer Burger.
21 March 2024
Press Releases

Homburger advised wefox in connection with a EUR 50 m revolving credit facility agreement and its USD 55 m Series D extension funding round

On May 17, 2023, the Berlin-based insurtech wefox announced that it has secured a EUR 50 m revolving credit facility arranged by J.P. Morgan Securities plc and Barclays Bank PLC, following a USD 55 m second close in its Series D that was completed earlier this year at a USD 4.5 bn valuation with investments from existing and new investors, including Squarepoint Capital.
21 March 2024
Press Releases

Homburger advises banks on CABB group’s high yield bond and RCF refinancing

Homburger advised the initial purchasers and arrangers in connection with CABB group’s EUR 250 m senior secured floating rate notes and EUR 420 m 8.75% senior secured fixed rate notes due 2028 and a new EUR 110 m revolving credit facility. Homburger advised the initial purchasers with respect to all Swiss legal aspects of the transaction.
21 March 2024
Press Releases

Homburger advised Siegfried on its acquisition of a 95% stake in DiNAMIQS

Siegfried and DiNAQOR AG entered into an agreement relating to the acquisition by Siegfried of a 95% stake in DiNAQOR DiNAMIQS AG (DiNAMIQS), a Swiss-based biotechnology company focused on the development and manufacturing of viral vectors for cell and gene therapies. Siegfried will bring DiNAMIQS’ capabilities to commercial scale and establish DiNAMIQS as a best-in-class biotech CDMO for cell and gene therapies. Through this acquisition, Siegfried further expands its footprint in the biologics space and will create significant mid to long-term growth opportunities in a very dynamic market segment.
21 March 2024
Press Releases

Homburger advises PHOENIX Pharma Switzerland on the closing of its joint venture with Voigt Group

After receiving clearance from the Swiss Competition Commission, PHOENIX Pharma Switzerland and the Voigt Group completed the transaction to establish avosano AG, a 50:50 joint venture on April 28, 2023. This closing marks the start of the joint future of Amedis-UE AG, Voigt AG Pharma Grosshandel and Voigt Industrie Service AG under the umbrella of avosano AG.
21 March 2024
Press Releases

Homburger advises Scaled Agile on its acquisition of Rentouch

On April 20, 2023, Scaled Agile Inc., a portfolio company of Eurazeo SE (Euronext Paris: RF), one of Europe's leading private equity firms, announced its acquisition of Rentouch, a Swiss-based company specializing in software for visualizing agile planning events across multiple agile teams with SAFe®. This acquisition aims to accelerate Scaled Agile's goal to redefine the way the world's leading organizations identify and deliver customer value, capitalize on emerging opportunities, and improve business outcomes through integrated solutions that help teams unlock better ways of working.
04 May 2023
Press Releases

Homburger advised Valaris Limited on the private placement of USD 700 m senior secured notes and an up to USD 375 m credit agreement

On April 19, 2023, Valaris Limited and its wholly-owned subsidiary, Valaris Finance Company LLC, closed the private placement of USD 700 m 8.375% senior secured second lien notes due 2030 and a senior secured first lien five-year credit agreement providing for commitments of up to USD 375 m. Valaris Limited is the industry leader in offshore drilling services across all water depths and geographies.
27 April 2023
Press Releases

Homburger advised Addex Therapeutics Ltd on new PIPE transaction

On April 5, 2023, allosteric modulation company Addex Therapeutics Ltd in Plan-les-Ouates, Geneva (SIX: ADXN) announced that it has completed an equity financing transaction with a healthcare-focused institutional investor, pursuant to which Addex agreed to sell 7,999,998 shares in the form of 1,333,333 American Depositary Shares («ADSs») at a gross purchase price of USD 0.95 per ADS, which is equivalent to CHF 0.145 per share. Each ADS represents six shares. Additionally, Addex has issued to the investor ordinary warrants to purchase up to 5,263,158 ADSs, as well as pre-funded warrants to purchase up to 3,929,825 ADSs in a concurrent private placement.
12 April 2023
Press Releases

Homburger advises Zürcher Kantonalbank on the issuance of its inaugural CHF 425 m Bail-in Bonds

On April 5, 2023, Zürcher Kantonalbank priced its inaugural CHF 425 m Bail-in Bond issuance. ZKB's Bail-in Bonds are novel instruments which have been designed and issued on the basis of a new legal framework allowing Cantonal Banks to issue Total-Loss-Absorbing-Capacity (TLAC) Bonds. In the event that FINMA orders the partial or complete reduction of the bondholders' claims under the Bail-in Bonds the bondholders are entitled to receive a Recovery Certificate. Such Recovery Certificate includes claims, subject to multiple conditions precedent, for subsequent future compensation payments for the full or partial reduction of the bondholders' claims under the Bail-in Bonds.
12 April 2023
Press Releases

Homburger advised Implenia on the acquisition of Wincasa

On March 30, 2023, Implenia AG (SIX: IMPN), Switzerland's leading real estate and construction service provider, announced that it had agreed to purchase Wincasa AG for CHF 171.6 m from Swiss Prime Site AG (SIX: SPSN). Wincasa is the leading Swiss real estate service provider with more than 250,000 managed properties, CHF 81 bn in assets under management and 1,350 employees (FTE). The closing of the transaction is planned for the second quarter of 2023, subject to regulatory approvals.
04 April 2023
Press Releases

Homburger advises Solenis on the acquisition of Diversey

On March 8, 2023, Solenis announced that it has entered into a definitive merger agreement under which Solenis will acquire Diversey in an all-cash transaction valued at an enterprise value of approximately USD 4.6 bn. Upon completion of the merger, Diversey will become a private company. Headquartered in Wilmington, Delaware, Solenis is a leading manufacturer of specialty chemicals used in water-intensive industries, which was acquired by Platinum Equity in 2021. Diversey is a leading provider of hygiene, infection prevention and cleaning solutions based in Fort Mill, South Carolina. The transaction is expected to be completed in the second half of 2023, subject to customary closing conditions. Homburger acts as Swiss transaction counsel to Solenis. The Homburger team includes Andreas Müller, Karin Mattle and Pepe Hünerwadel (all Corporate / M&A), Kristina Martinovic (Employment and Executive Compensation) as well as Gregor Bühler and Hélène Bruderer (both IP / IT). Contact Nanding Susso / Marketing / [email protected] March 30, 2023
04 April 2023
Press Releases

Homburger advised a syndicate of banks in connection with the financing of the acquisition of Norline AG

Homburger acted as counsel to Zürcher Kantonalbank as mandated lead arranger, agent, security agent and original lender as well as Credit Suisse (Switzerland) Ltd. and Migros Bank AG as mandated lead arrangers and original lenders in connection with the financing of the acquisition of Norline AG by private equity firm Argos Wityu. Norline AG is a leading provider of outsourcing services in the heating, ventilation, air conditioning and plumbing sector in Switzerland.
28 March 2023
Press Releases

Homburger advised Nestlé on the issuance of an aggregate of USD 3 bn notes through an institutional (Rule 144A) offering in the United States of America

On March 14, 2023, Nestlé Holdings, Inc. successfully completed its issuance of USD 1 bn 5.250% Notes due 2026, USD 850 m 5.000% Notes due 2028, USD 500 m 4.950% Notes due 2030, and USD 650 m 4.850% Notes due 2033. The Notes are guaranteed by the Nestlé group's Swiss parent company Nestlé S.A. The offering of the Notes was done in reliance on Rule 144A and Regulation S under the U.S. Securities Act.
20 March 2023
Press Releases

Homburger advised Credit Suisse on boardroom matters, contingency planning, transactional options, bank regulatory and corporate law aspects in connection with the various measures to support its liquidity situation and the merger of Credit Suisse with UBS

On March 19, 2023, Credit Suisse announced that Credit Suisse and UBS have entered into a merger agreement following the intervention of the Swiss Federal Department of Finance, the Swiss National Bank and the Swiss Financial Market Supervisory Authority FINMA. UBS will be the surviving entity upon closing of the merger transaction. Homburger advised Credit Suisse on boardroom matters, contingency planning, transactional options, bank regulatory and corporate law aspects in connection with the various measures to support its liquidity situation and the merger of Credit Suisse with UBS.
20 March 2023
Press Releases

Homburger advised Santhera on its financing through a private placement of shares and upsizing of existing financing

On February 28, 2023, Santhera Pharmaceuticals Holding AG (SIX: SANN) announced a private placement of shares and an amendment of its existing financing with funds managed by Highbridge Capital Management, LLC, to provide up to CHF 22.2 m in aggregate, subject to certain milestones and conditions. In addition, Santhera issued 40 m shares in an ordinary capital increase, 37 m of which will be held in treasury for the time being.
07 March 2023
Press Releases

Homburger advises Noema Pharma AG on its USD 112 m Series B financing round

On March 7, 2023, Noema Pharma AG announced that it has successfully closed an oversubscribed Series B financing round, raising CHF 103 m (approx. USD 112 m) from new and existing investors. The round was co-led by the European healthcare focused investment firms Forbion and Jeito Capital. UPMC Enterprises and an additional new investor joined existing investors Sofinnova Partners, Polaris Partners, Gilde Healthcare and Invus to complete the round.
07 March 2023
Press Releases

Homburger advised UBS Group AG on its issuance of USD 4 bn Fixed Rate/Fixed Rate Callable Senior Notes under its Senior Debt Programme

On January 12, 2023, UBS Group AG successfully completed its issuance of USD 1.75 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due January 2027 and USD 2.25 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due January 2034 under its Senior Debt Programme. The Notes are bail-inable (TLAC) bonds that are eligible to count towards UBS Group AG's Swiss gone concern requirement.
24 January 2023
Press Releases

Homburger advised Juuri Partners Oy on its investment in DAF Group Oy to accelerate Subway's growth in Finland and Sweden

On January 19, 2023, the Finnish private equity firm Juuri Partners Oy has announced its investment in DAF Group Oy, which is responsible for managing Subway’s business in Finland and Sweden through a long-term development agreement. Through the investment, DAF Group will expand its operations in Finland and Sweden, intending to strengthen its restaurant network and invest in its current restaurants’ digitalization and improved guest experience.
24 January 2023
Press Releases

Homburger advised BioVersys AG on the extension of its Series C fundraising round

On January 5, 2023, BioVersys AG, a privately held clinical stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies for life-threatening multidrug-resistant bacterial infections and targeted microbiome modulation, announced that the AMR Action Fund has joined existing investors of BioVersys, extending the total proceeds of the Series C round to CHF 32.6 m. BioVersys represents the first European-based investment of the AMR Action Fund.
12 January 2023
Press Releases

Homburger advised Credit Suisse AG on its registered offering of USD 3.75 bn aggregate principal amount of senior notes

On January 9, 2023, Credit Suisse AG successfully completed its registered offering of USD 3.75 bn aggregate principal amount of senior notes. The offering consisted of USD 1.25 bn aggregate principal amount of 7.950% senior notes due 2025 and USD 2.5 bn aggregate principal amount of 7.500 per cent. due 2028. The notes were issued under Credit Suisse AG's U.S. medium-term note program and pursuant to its shelf registration statement on file with the U.S. Securities and Exchange Commission.
11 January 2023
Press Releases

Homburger advises Perfetti Van Melle on its USD 1.35 bn acquisition of Mondelez's gum business

On December 19, 2022, Perfetti Van Melle and Mondelez International announced that they have entered into a definitive agreement regarding the sale and purchase of Mondelez's developed-market gum business in the United States, Canada and Europe. The transaction, which is subject to customary closing conditions, is expected to close in Q4 2023.
11 January 2023
Press Releases

Homburger advised OC Oerlikon on the acquisition of Riri

On December 16, 2022, OC Oerlikon Corporation AG, Pfäffikon (SIX: OERL), a global innovation powerhouse for surface engineering, polymer processing and additive manufacturing, announced that it has signed a definitive agreement to acquire Riri, a leading provider of coated metal accessories for the luxury fashion industry.
11 January 2023
Press Releases

Homburger advised 21Shares on cash tender offer for exchange traded products

On October 11, 2022, 21Shares AG (21Shares), the world's largest issuer of cryptocurrency exchange traded products, launched a first-of-its-kind public cash tender offer for all out-standing exchange traded products of the series 21Shares Terra Classic ETP issued by 21Shares under its Exchange Traded Products Programme.
12 December 2022
Press Releases

Homburger advised Credit Suisse on its inaugural EUR 750 m Swiss Covered Bonds Issuance

On December 7, 2022, Credit Suisse (Switzerland) Ltd. issued an aggregate of EUR 750 m of covered bonds. The new series, EUR 750 m Fixed-Rate Covered Bonds due 2026, has been Credit Suisse (Switzerland) Ltd.’s inaugural EUR covered bonds issuance. The covered bonds were issued under its Swiss Covered Bonds Programme and will be listed on the SIX Swiss Exchange.
12 December 2022